Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Henning Walczak
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Chemicals & Drugs
Physiology
Anatomy
Living Beings
Sign-in to see full Profile
Network (preview)
26
Krammer, Peter
13
Sprick, Martin
12
Haas, Tobias
11
Sykora, Jaromir
11
Möller, Peter
10
Ganten, Tom
9
Debatin, Klaus-Michael
9
Sträter, Jörn
8
Koschny, Ronald
7
Stremmel, Wolfgang
5
Leverkus, Martin
5
Bröcker, Eva-B
5
Grosse-Wilde, Anne
4
Hasel, Cornelia
4
Stahl, Heiko
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Henning Walczak (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Ganten Tom M; Sykora Jaromir; Koschny Ronald; Batke Emanuela; Aulmann Sebastian; Mansmann Ulrich; Stremmel Wolfgang; Sinn Hans-Peter; Walczak Henning
Prognostic significance of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor expression in patients with breast cancer.
Journal of molecular medicine (Berlin, Germany) 2009;87(10):995-1007.
-
2009: Vogler Meike; Walczak Henning; Stadel Dominic; Haas Tobias L; Genze Felicitas; Jovanovic Marjana; Bhanot Umesh; Hasel Cornelia; Möller Peter; Gschwend Jürgen E; Simmet Thomas; Debatin Klaus-Michael; Fulda Simone
Small molecule XIAP inhibitors enhance TRAIL-induced apoptosis and antitumor activity in preclinical models of pancreatic carcinoma.
Cancer research 2009;69(6):2425-34.
-
2009: Macher-Goeppinger Stephan; Aulmann Sebastian; Tagscherer Katrin E; Wagener Nina; Haferkamp Axel; Penzel Roland; Brauckhoff Antje; Hohenfellner Markus; Sykora Jaromir; Walczak Henning; Teh Bin T; Autschbach Frank; Herpel Esther; Schirmacher Peter; Roth Wilfried
Prognostic value of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and TRAIL receptors in renal cell cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(2):650-9.
-
2008: Grund Kerstin; Ahmadi Rezvan; Jung Fortunata; Funke Verena; Gdynia Georg; Benner Axel; Sykora Jaromir; Walczak Henning; Joos Stefan; Felsberg Jörg; Reifenberger Guido; Wiestler Otmar D; Herold-Mende Christel; Roth Wilfried
Troglitazone-mediated sensitization to TRAIL-induced apoptosis is regulated by proteasome-dependent degradation of FLIP and ERK1/2-dependent phosphorylation of BAD.
Cancer biology & therapy 2008;7(12):1982-90.
-
2008: Vogler Meike; Walczak Henning; Stadel Dominic; Haas Tobias L; Genze Felicitas; Jovanovic Marjana; Gschwend Jürgen E; Simmet Thomas; Debatin Klaus-Michael; Fulda Simone
Targeting XIAP bypasses Bcl-2-mediated resistance to TRAIL and cooperates with TRAIL to suppress pancreatic cancer growth in vitro and in vivo.
Cancer research 2008;68(19):7956-65.
-
2008: Eckert A; Böck B C; Tagscherer K E; Haas T L; Grund K; Sykora J; Herold-Mende C; Ehemann V; Hollstein M; Chneiweiss H; Wiestler O D; Walczak H; Roth W
The PEA-15/PED protein protects glioblastoma cells from glucose deprivation-induced apoptosis via the ERK/MAP kinase pathway.
Oncogene 2008;27(8):1155-66.
-
2008: Grosse-Wilde Anne; Voloshanenko Oksana; Bailey S Lawrence; Longton Gary M; Schaefer Uta; Csernok Andreea I; Schütz Günther; Greiner Erich F; Kemp Christopher J; Walczak Henning
TRAIL-R deficiency in mice enhances lymph node metastasis without affecting primary tumor development.
The Journal of clinical investigation 2008;118(1):100-10.
-
2008: Verbrugge I; de Vries E; Tait S W G; Wissink E H J; Walczak H; Verheij M; Borst J
Ionizing radiation modulates the TRAIL death-inducing signaling complex, allowing bypass of the mitochondrial apoptosis pathway.
Oncogene 2008;27(5):574-84.
-
2008: Walczak Henning; Haas Tobias L
Biochemical analysis of the native TRAIL death-inducing signaling complex.
Methods in molecular biology (Clifton, N.J.) 2008;414():221-39.
-
2007: Koschny Ronald; Walczak Henning; Ganten Tom M
The promise of TRAIL--potential and risks of a novel anticancer therapy.
Journal of molecular medicine (Berlin, Germany) 2007;85(9):923-35.
-
2007: Gassler Nikolaus; Roth Wilfried; Funke Benjamin; Schneider Armin; Herzog Frank; Tischendorf Jens J W; Grund Kerstin; Penzel Roland; Bravo Ignacio G; Mariadason John; Ehemann Volker; Sykora Jaromir; Haas Tobias L; Walczak Henning; Ganten Tom; Zentgraf Hanswalter; Erb Peter; Alonso Angel; Autschbach Frank; Schirmacher Peter; Knüchel Ruth; Kopitz Jürgen
Regulation of enterocyte apoptosis by acyl-CoA synthetase 5 splicing.
Gastroenterology 2007;133(2):587-98.
-
2007: Koschny Ronald; Holland Heidrun; Sykora Jaromir; Haas Tobias L; Sprick Martin R; Ganten Tom M; Krupp Wolfgang; Bauer Manfred; Ahnert Peter; Meixensberger Jürgen; Walczak Henning
Bortezomib sensitizes primary human astrocytoma cells of WHO grades I to IV for tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(11):3403-12.
-
2007: Koschny Ronald; Ganten Tom M; Sykora Jaromir; Haas Tobias L; Sprick Martin R; Kolb Armin; Stremmel Wolfgang; Walczak Henning
TRAIL/bortezomib cotreatment is potentially hepatotoxic but induces cancer-specific apoptosis within a therapeutic window.
Hepatology (Baltimore, Md.) 2007;45(3):649-58.
-
2007: Wenger T; Mattern J; Haas T L; Sprick M R; Walczak H; Debatin K-M; Büchler M W; Herr I
Apoptosis mediated by lentiviral TRAIL transfer involves transduction-dependent and -independent effects.
Cancer gene therapy 2007;14(3):316-26.
-
2007: Ganten T M; Aravena E; Sykora J; Koschny R; Mohr J; Rudi J; Stremmel W; Walczak H
Helicobacter pylori-induced apoptosis in T cells is mediated by the mitochondrial pathway independent of death receptors.
European journal of clinical investigation 2007;37(2):117-25.
-
2007: Schaefer Uta; Voloshanenko Oksana; Willen Daniela; Walczak Henning
TRAIL: a multifunctional cytokine.
Frontiers in bioscience : a journal and virtual library 2007;12():3813-24.
-
2007: Falschlehner Christina; Emmerich Christoph H; Gerlach Björn; Walczak Henning
TRAIL signalling: decisions between life and death.
The international journal of biochemistry & cell biology 2007;39(7-8):1462-75.
-
2006: Wenger T; Mattern J; Penzel R; Gassler N; Haas T L; Sprick M R; Walczak H; Krammer P H; Debatin K-M; Herr I
Specific resistance upon lentiviral TRAIL transfer by intracellular retention of TRAIL receptors.
Cell death and differentiation 2006;13(10):1740-51.
-
2006: Wissink Esther H J; Verbrugge Inge; Vink Stefan R; Schader Manuela B; Schaefer Uta; Walczak Henning; Borst Jannie; Verheij Marcel
TRAIL enhances efficacy of radiotherapy in a p53 mutant, Bcl-2 overexpressing lymphoid malignancy.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2006;80(2):214-22.
-
2006: Kern Michael A; Haugg Anke M; Koch Andreas F; Schilling Tobias; Breuhahn Kai; Walczak Henning; Fleischer Binje; Trautwein Christian; Michalski Christoph; Schulze-Bergkamen Henning; Friess Helmut; Stremmel Wolfgang; Krammer Peter H; Schirmacher Peter; Müller Martina
Cyclooxygenase-2 inhibition induces apoptosis signaling via death receptors and mitochondria in hepatocellular carcinoma.
Cancer research 2006;66(14):7059-66.
-
2006: Ganten Tom M; Koschny Ronald; Sykora Jaromir; Schulze-Bergkamen Henning; Büchler Peter; Haas Tobias L; Schader Manuela B; Untergasser Andreas; Stremmel Wolfgang; Walczak Henning
Preclinical differentiation between apparently safe and potentially hepatotoxic applications of TRAIL either alone or in combination with chemotherapeutic drugs.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(8):2640-6.
-
2005: Ganten Tom M; Koschny Ronald; Haas Tobias L; Sykora Jaromir; Li-Weber Min; Herzer Kerstin; Walczak Henning
Proteasome inhibition sensitizes hepatocellular carcinoma cells, but not human hepatocytes, to TRAIL.
Hepatology (Baltimore, Md.) 2005;42(3):588-97.
-
2005: Herzer Kerstin; Ganten Tom M; Schulze-Bergkamen Henning; Grosse-Wilde Anne; Koschny Ronald; Krammer Peter H; Walczak Henning
Transforming growth factor beta can mediate apoptosis via the expression of TRAIL in human hepatoma cells.
Hepatology (Baltimore, Md.) 2005;42(1):183-92.
-
2004: Wachter Tina; Sprick Martin; Hausmann Dominikus; Kerstan Andreas; McPherson Kirsty; Stassi Giorgio; Bröcker Eva-B; Walczak Henning; Leverkus Martin
cFLIPL inhibits tumor necrosis factor-related apoptosis-inducing ligand-mediated NF-kappaB activation at the death-inducing signaling complex in human keratinocytes.
The Journal of biological chemistry 2004;279(51):52824-34.
-
2004: Ganten T M; Haas T L; Sykora J; Stahl H; Sprick M R; Fas S C; Krueger A; Weigand M A; Grosse-Wilde A; Stremmel W; Krammer P H; Walczak H
Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs.
Cell death and differentiation 2004;11 Suppl 1():S86-96.
-
2004: Shinbori Toshifumi; Walczak Henning; Krammer Peter H
Activated T killer cells induce apoptosis in lung epithelial cells and the release of pro-inflammatory cytokine TNF-alpha.
European journal of immunology 2004;34(6):1762-70.
-
2004: Demjen Deana; Klussmann Stefan; Kleber Susanne; Zuliani Cecilia; Stieltjes Bram; Metzger Corinna; Hirt Ulrich A; Walczak Henning; Falk Werner; Essig Marco; Edler Lutz; Krammer Peter H; Martin-Villalba Ana
Neutralization of CD95 ligand promotes regeneration and functional recovery after spinal cord injury.
Nature medicine 2004;10(4):389-95.
-
2004: Sprick Martin R; Walczak Henning
The interplay between the Bcl-2 family and death receptor-mediated apoptosis.
Biochimica et biophysica acta 2004;1644(2-3):125-32.
-
2003: Leverkus Martin; Sprick Martin R; Wachter Tina; Denk Andrea; Bröcker Eva-Bettina; Walczak Henning; Neumann Manfred
TRAIL-induced apoptosis and gene induction in HaCaT keratinocytes: differential contribution of TRAIL receptors 1 and 2.
The Journal of investigative dermatology 2003;121(1):149-55.
-
2003: Hasel Cornelia; Dürr Susanne; Rau Bettina; Sträter Jörn; Schmid Roland M; Walczak Henning; Bachem Max G; Möller Peter
In chronic pancreatitis, widespread emergence of TRAIL receptors in epithelia coincides with neoexpression of TRAIL by pancreatic stellate cells of early fibrotic areas.
Laboratory investigation; a journal of technical methods and pathology 2003;83(6):825-36.
-
2003: Washburn Birgit; Weigand Markus A; Grosse-Wilde Anne; Janke Markus; Stahl Heiko; Rieser Eva; Sprick Martin R; Schirrmacher Volker; Walczak Henning
TNF-related apoptosis-inducing ligand mediates tumoricidal activity of human monocytes stimulated by Newcastle disease virus.
Journal of immunology (Baltimore, Md. : 1950) 2003;170(4):1814-21.
-
2003: Leverkus Martin; Sprick Martin R; Wachter Tina; Mengling Thilo; Baumann Bernd; Serfling Edgar; Bröcker Eva-B; Goebeler Matthias; Neumann Manfred; Walczak Henning
Proteasome inhibition results in TRAIL sensitization of primary keratinocytes by removing the resistance-mediating block of effector caspase maturation.
Molecular and cellular biology 2003;23(3):777-90.
-
2002: Sträter Jörn; Hinz Ulf; Walczak Henning; Mechtersheimer Gunhild; Koretz Karin; Herfarth Christian; Möller Peter; Lehnert Thomas
Expression of TRAIL and TRAIL receptors in colon carcinoma: TRAIL-R1 is an independent prognostic parameter.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(12):3734-40.
-
2002: Sprick Martin R; Rieser Eva; Stahl Heiko; Grosse-Wilde Anne; Weigand Markus A; Walczak Henning
Caspase-10 is recruited to and activated at the native TRAIL and CD95 death-inducing signalling complexes in a FADD-dependent manner but can not functionally substitute caspase-8.
The EMBO journal 2002;21(17):4520-30.
-
2002: Mueller Sebastian; Weber Angelika; Fritz Reiner; Mütze Sabine; Rost Daniel; Walczak Henning; Völkl Alfred; Stremmel Wolfgang
Sensitive and real-time determination of H2O2 release from intact peroxisomes.
The Biochemical journal 2002;363(Pt 3):483-91.
-
2002: Müerköster S; Weigand M A; Choi C; Walczak H; Schirrmacher V; Umansky V
Superantigen reactive Vbeta6+ T cells induce perforin/granzyme B mediated caspase-independent apoptosis in tumour cells.
British journal of cancer 2002;86(5):828-36.
-
2002: Sträter Jörn; Walczak Henning; Pukrop Tanja; Von Müller Lutz; Hasel Cornelia; Kornmann Marko; Mertens Thomas; Möller Peter
TRAIL and its receptors in the colonic epithelium: a putative role in the defense of viral infections.
Gastroenterology 2002;122(3):659-66.
-
2001: Raftery M J; Schwab M; Eibert S M; Samstag Y; Walczak H; Schönrich G
Targeting the function of mature dendritic cells by human cytomegalovirus: a multilayered viral defense strategy.
Immunity 2001;15(6):997-1009.
-
2001: Walczak H; Sprick M R
Biochemistry and function of the DISC.
Trends in biochemical sciences 2001;26(7):452-3.
-
2001: Sträter J; Walczak H; Hasel C; Melzner I; Leithäuser F; Möller P
CD95 ligand (CD95L) immunohistochemistry: a critical study on 12 antibodies.
Cell death and differentiation 2001;8(3):273-8.
-
2000: Leverkus M; Walczak H; McLellan A; Fries H W; Terbeck G; Bröcker E B; Kämpgen E
Maturation of dendritic cells leads to up-regulation of cellular FLICE-inhibitory protein and concomitant down-regulation of death ligand-mediated apoptosis.
Blood 2000;96(7):2628-31.
-
2000: Sprick M R; Weigand M A; Rieser E; Rauch C T; Juo P; Blenis J; Krammer P H; Walczak H
FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2.
Immunity 2000;12(6):599-609.
-
2000: Walczak H; Bouchon A; Stahl H; Krammer P H
Tumor necrosis factor-related apoptosis-inducing ligand retains its apoptosis-inducing capacity on Bcl-2- or Bcl-xL-overexpressing chemotherapy-resistant tumor cells.
Cancer research 2000;60(11):3051-7.
-
2000: Walczak H; Krammer P H
The CD95 (APO-1/Fas) and the TRAIL (APO-2L) apoptosis systems.
Experimental cell research 2000;256(1):58-66.
-
2000: Leverkus M; Neumann M; Mengling T; Rauch C T; Bröcker E B; Krammer P H; Walczak H
Regulation of tumor necrosis factor-related apoptosis-inducing ligand sensitivity in primary and transformed human keratinocytes.
Cancer research 2000;60(3):553-9.
-
2000: Bouchon A; Krammer P H; Walczak H
Critical role for mitochondria in B cell receptor-mediated apoptosis.
European journal of immunology 2000;30(1):69-77.
-
1999: Raftery M J; Behrens C K; Müller A; Krammer P H; Walczak H; Schönrich G
Herpes simplex virus type 1 infection of activated cytotoxic T cells: Induction of fratricide as a mechanism of viral immune evasion.
The Journal of experimental medicine 1999;190(8):1103-14.
-
1999: Schmitz I; Walczak H; Krammer P H; Peter M E
Differences between CD95 type I and II cells detected with the CD95 ligand.
Cell death and differentiation 1999;6(9):821-2.
-
1999: Walczak H; Miller R E; Ariail K; Gliniak B; Griffith T S; Kubin M; Chin W; Jones J; Woodward A; Le T; Smith C; Smolak P; Goodwin R G; Rauch C T; Schuh J C; Lynch D H
Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.
Nature medicine 1999;5(2):157-63.
-
1999: Sträter J; Mariani S M; Walczak H; Rücker F G; Leithäuser F; Krammer P H; Möller P
CD95 ligand (CD95L) in normal human lymphoid tissues: a subset of plasma cells are prominent producers of CD95L.
The American journal of pathology 1999;154(1):193-201.
-
1998: Li-Weber M; Laur O; Hekele A; Coy J; Walczak H; Krammer P H
A regulatory element in the CD95 (APO-1/Fas) ligand promoter is essential for responsiveness to TCR-mediated activation.
European journal of immunology 1998;28(8):2373-83.
-
1997: Degli-Esposti M A; Smolak P J; Walczak H; Waugh J; Huang C P; DuBose R F; Goodwin R G; Smith C A
Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family.
The Journal of experimental medicine 1997;186(7):1165-70.
-
1997: Walczak H; Degli-Esposti M A; Johnson R S; Smolak P J; Waugh J Y; Boiani N; Timour M S; Gerhart M J; Schooley K A; Smith C A; Goodwin R G; Rauch C T
TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL.
The EMBO journal 1997;16(17):5386-97.
-
1997: Sträter J; Wellisch I; Riedl S; Walczak H; Koretz K; Tandara A; Krammer P H; Möller P
CD95 (APO-1/Fas)-mediated apoptosis in colon epithelial cells: a possible role in ulcerative colitis.
Gastroenterology 1997;113(1):160-7.
-
1996: Sträter J; Walczak H; Krammer P H; Möller P
Simultaneous in situ detection of mRNA and apoptotic cells by combined hybridization and TUNEL.
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 1996;44(12):1497-9.
-
1996: Herr I; Balemans L; Böhler T; Walczak H; Debatin K M
Monitoring of CD95 (APO-1/Fas) ligand expression in human T cells by quantitative RT-PCR.
Cell death and differentiation 1996;3(3):299-305.
-
1996: Möller P; Walczak H; Reidl S; Sträter J; Krammer P H
Paneth cells express high levels of CD95 ligand transcripts: a unique property among gastrointestinal epithelia.
The American journal of pathology 1996;149(1):9-13.
-
1996: Walczak H; Dhein J; Peter M E; Krammer P H
Educational Corner: Activation-induced T cell death.
Cell death and differentiation 1996;3(2):245.
-
1996: Sträter J; Walczak H; Wellisch I; Riedl S; Koretz K; Krammer P H; Möller P
[Normal colon epithelium is highly sensitive to CD95-induced apoptosis. Indication for a role of cell death-induced CD95/CL95L systems under inflammatory inflammatory conditions?]
Verhandlungen der Deutschen Gesellschaft für Pathologie 1996;80():217.
-
1995: Peter M E; Dhein J; Ehret A; Hellbardt S; Walczak H; Moldenhauer G; Krammer P H
APO-1 (CD95)-dependent and -independent antigen receptor-induced apoptosis in human T and B cell lines.
International immunology 1995;7(11):1873-7.
-
1995: Dhein J; Walczak H; Westendorp M O; Bäumler C; Stricker K; Frank R; Debatin K M; Krammer P H
Molecular mechanisms of APO-1/Fas(CD95)-mediated apoptosis in tolerance and AIDS.
Behring Institute Mitteilungen 1995;(96):13-20.
-
1995: Westendorp M O; Frank R; Ochsenbauer C; Stricker K; Dhein J; Walczak H; Debatin K M; Krammer P H
Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120.
Nature 1995;375(6531):497-500.
-
1995: Dhein J; Walczak H; Bäumler C; Debatin K M; Krammer P H
Autocrine T-cell suicide mediated by APO-1/(Fas/CD95)
Nature 1995;373(6513):438-41.
-
1994: Krammer P H; Dhein J; Walczak H; Behrmann I; Mariani S; Matiba B; Fath M; Daniel P T; Knipping E; Westendorp M O
The role of APO-1-mediated apoptosis in the immune system.
Immunological reviews 1994;142():175-91.
-
1994: Behrmann I; Walczak H; Krammer P H
Structure of the human APO-1 gene.
European journal of immunology 1994;24(12):3057-62.
-
1994: Schulze-Osthoff K; Walczak H; Dröge W; Krammer P H
Cell nucleus and DNA fragmentation are not required for apoptosis.
The Journal of cell biology 1994;127(1):15-20.
-
1994: Dhein J; Behrmann I; Daniel P T; Debatin K M; Klas C; Möller P; Oehm A; Trauth B C; Walczak H; Krammer P H
APO-I-mediated apoptosis in normal and malignant lymphocytes.
Biochemical Society transactions 1994;22(3):598-600.
-
1992: Lichter P; Walczak H; Weitz S; Behrmann I; Krammer P H
The human APO-1 (APT) antigen maps to 10q23, a region that is syntenic with mouse chromosome 19.
Genomics 1992;14(1):179-80.
Sign-in to see more
